The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis
Introduction: Clopidogrel and aspirin were proved to have benefit in symptomatic intracranial stenosis. CYP2C19 polymorphism (CYP2C19*1, CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles) affects efficacy of clopidogrel. Epidemiologic study of CYP2C19 polymorphism has been conducted in Thai po...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-01-01
|
| Series: | Cerebrovascular Diseases Extra |
| Online Access: | https://karger.com/article/doi/10.1159/000543331 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|